Roberto Reyes-Sanchez

Mexico City, DIF, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Addressing the need for genetic cancer risk assessment in Mexico: From establishment of a formal program to delivery innovation and expansion.

Addressing the need for genetic cancer risk assessment in Mexico: From establishment of a formal program to delivery innovation and expansion.

Journal: Genetics in medicine open

Published: January 30, 2024

Association of Carcinoembryonic Antigen Reduction With Progression-free and Overall Survival Improvement in Advanced Non-small-cell Lung Cancer.

Association of Carcinoembryonic Antigen Reduction With Progression-free and Overall Survival Improvement in Advanced Non-small-cell Lung Cancer.

Journal: Clinical lung cancer

Published: November 05, 2020

Association of Lung Adenocarcinoma Subtypes According to the IASLC/ATS/ERS Classification and Programmed Cell Death Ligand 1 (PD-L1) Expression in Tumor Cells.

Association of Lung Adenocarcinoma Subtypes According to the IASLC/ATS/ERS Classification and Programmed Cell Death Ligand 1 (PD-L1) Expression in Tumor Cells.

Journal: Pathology oncology research : POR

Published: August 21, 2020

A Patient With Newly Diagnosed, Advanced EGFR-Mutated Non-Small Cell Lung Cancer.

A Patient With Newly Diagnosed, Advanced EGFR-Mutated Non-Small Cell Lung Cancer.

Journal: Oncology (Williston Park, N.Y.)

Published: July 10, 2020

Onco-omics Approaches and Applications in Clinical Trials for Cancer Patients.

Onco-omics Approaches and Applications in Clinical Trials for Cancer Patients.

Journal: Advances in experimental medicine and biology

Published: November 13, 2019

Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer.

Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer.

Journal: BMC cancer

Published: September 11, 2015

Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP).

Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP).

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: January 31, 2015

The impact of common and rare EGFR mutations in response to EGFR tyrosine kinase inhibitors and platinum-based chemotherapy in patients with non-small cell lung cancer.

The impact of common and rare EGFR mutations in response to EGFR tyrosine kinase inhibitors and platinum-based chemotherapy in patients with non-small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: October 18, 2014

Relevance of the novel IASLC/ATS/ERS classification of lung adenocarcinoma in advanced disease.

Relevance of the novel IASLC/ATS/ERS classification of lung adenocarcinoma in advanced disease.

Journal: The European respiratory journal

Published: January 18, 2014

Clinical and pathological characteristics, outcome and mutational profiles regarding non-small-cell lung cancer related to wood-smoke exposure.

Clinical and pathological characteristics, outcome and mutational profiles regarding non-small-cell lung cancer related to wood-smoke exposure.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: June 05, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026